DHR

Danaher Price

Closed
DHR
$202.45
-$1.44(-0.70%)

*Data last updated: 2026-08-17 04:27 (UTC+8)

As of 2026-08-17 04:27, Danaher (DHR) is priced at $202.45, with a total market cap of $134.81B, a P/E ratio of 45.15, and a dividend yield of 0.75%. Today, the stock price fluctuated between $201.72 and $203.96. The current price is 0.36% above the day's low and 0.74% below the day's high, with a trading volume of 2.43M. Over the past 52 weeks, DHR has traded between $160.93 to $242.80, and the current price is -16.61% away from the 52-week high.

Key Stats

Yesterday's Close$192.78
Market Cap$134.81B
Volume2.43M
P/E Ratio45.15
Dividend Yield (TTM)0.75%
Dividend Amount$0.40
Diluted EPS (TTM)5.21
Net Income (FY)$3.61B
Revenue (FY)$24.56B
Earnings Date2026-07-21
EPS Estimate1.83
Revenue Estimate$6.09B
Shares Outstanding699.32M
Beta (1Y)0.834
Ex-Dividend Date2026-06-26
Dividend Payment Date2026-07-31

Introduction

Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.
SectorHealthcare
IndustryMedical - Diagnostics & Research
CEORainer Blair
HeadquartersWashington,DC,US
Official Websitehttps://www.danaher.com
Employees (FY)60.00K
Average Revenue (1Y)$409.46K
Net Income per Employee$60.23K

DHR FAQ

What's the stock price of Danaher (DHR) today?

x
Danaher (DHR) is currently trading at $202.45, with a 24h change of -0.70%. The 52-week trading range is $160.93–$242.80.

What are the 52-week high and low prices for Danaher (DHR)?

x

What is the price-to-earnings (P/E) ratio of Danaher (DHR)? What does it indicate?

x

What is the market cap of Danaher (DHR)?

x

What is the most recent quarterly earnings per share (EPS) for Danaher (DHR)?

x

Should you buy or sell Danaher (DHR) now?

x

What factors can affect the stock price of Danaher (DHR)?

x

How to buy Danaher (DHR) stock?

x

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.